Over 10 Total Lots Up For Auction at One Location - CO 06/17

Hitachi's heavy ion beam therapy system starts treatment at Osaka Heavy Ion Therapy Center

Press releases may be edited for formatting or style | October 16, 2018 Rad Oncology Proton Therapy

(1) The system obtained manufacturing and marketing approval in accordance with Pharmaceutical and Medical Device Act on September 25, 2018.
(2) Real-time image gating is the technology collaboratively developed between Hokkaido University and Hitachi, supported by Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) of Japan Society for the Promotion of Science.
(3) The system obtained manufacturing and marketing approval in accordance with Pharmaceutical and Medical Device Act on October 10, 2018.

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats
About Hitachi, Ltd.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges, combining its operational technology, information technology, and products/systems. The company's consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Back to HCB News

You Must Be Logged In To Post A Comment